Category

Insights

CND Life Sciences Launches Patient Matters Video Series to Highlight the Importance of the Syn-One Test™ in Diagnosing Neurological Disorders

By Insights

A core value of CND Life Sciences is putting patients first. We understand that there’s a patient behind every Syn-One Test™ we perform. That’s why we’re launching the Patient Matters video series—hosted by former CNN anchor Daryn Kagan—to bring those patients’ stories to the forefront and demonstrate the importance of the Syn-One Test in helping clinicians make an objective and accurate diagnosis. 

Read More

We Can Perform Early Screening for Neurodegenerative Disorders. Does That Mean We Should?

By Insights

In the November 2020 issue of Movement Disorders, Dommershuijsen and his fellow researchers in the Netherlands wrote an excellent editorial on the ethical considerations of screening for rapid eye movement sleep behavior disorder (RBD) in the healthy general population. I wanted to use this blog to discuss why this question is such an important one to consider as discoveries in the alpha-synucleinopathies continue to advance.

Read More

Acting Out Your Dreams May Be Dangerous And Could Be an Early Sign of a Neurological Disorder

By Insights

It is 4:30 AM and you are sound asleep. Suddenly your significant other screams and starts punching and kicking you. You struggle to protect yourself and don’t understand what is happening. Your partner is very confused and extremely upset that they may have hurt you. This frightening scenario is estimated to occur in approximately 1% of the population, so this type of event happens in millions of households every night.

Read More